// App-Quantinova.ai

71 : Initial clinical experience with 6-hour enoxaparin regimen in opiate-treated patients undergoing primary percutaneous coronary intervention

Researchers

Presenter

  • Nadir Elamin

Principal Investigators

  • Thomas A Nelson

  • James D Richardson

  • Zulfiquar Adam

  • Arvindra Krishnamurthy

  • Javaid Iqbal

  • Kenneth P Morgan

  • Ian R Hall

  • Alexander Rothman

  • William A E Parker

  • Robert F Storey

  • Kok Weng Ow

  • David S Barmby

  • Dwayne Conway

  • Paul D Morris

  • Julian Gunn

Medical Centers

  • Sheffield Teaching Hospitals

  • The University of Sheffield

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • Aspartate aminotransferase

Drug/Treatment

  • Heparin

  • Enoxaparin

  • Enoxaparin sodium

  • Tirofiban hydrocloride

  • Heparin

  • Epimorph

  • Opiate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved